Mortality in Friedreich ataxia
- PMID: 21652007
- DOI: 10.1016/j.jns.2011.05.023
Mortality in Friedreich ataxia
Abstract
Background: Although cardiac dysfunction is widely accepted as the most common cause of mortality in Friedreich ataxia (FRDA), no studies have evaluated this since the advent of specific clinical and genetic diagnostic criteria.
Methods: We performed a retrospective study of FRDA patients to determine cause of death followed by a case-control analysis comparing characteristics of deceased patients with living, age- and sex-matched FRDA controls.
Results: Causes of death were cardiac dysfunction (59%), probable cardiac dysfunction (3.3%), non-cardiac (27.9%) or unknown (9.8%). Compared to non-cardiac deaths, cardiac deaths occurred earlier in the disease course (median 29 vs. 17years respectively). Congestive heart failure and arrhythmia were common causes of cardiac-related death. Compared to living, matched FRDA controls, deceased patients had longer triplet repeat lengths and higher rates of arrhythmia and dilated cardiomyopathy. The presence of hypertrophic cardiomyopathy did not differ between deceased and living patients.
Conclusion: Cardiac dysfunction was the most frequent cause of death (59%), most commonly from congestive heart failure or arrhythmia. Arrhythmia and dilated cardiomyopathy were significantly more common in deceased patients compared to matched FRDA controls, while in contrast, the presence of cardiac hypertrophy did not differ. More research is needed to establish the clinical significance of hypertrophy in FRDA.
Copyright © 2011 Elsevier B.V. All rights reserved.
Similar articles
-
A 22-Year Follow-up Study of Long-term Cardiac Outcome and Predictors of Survival in Friedreich Ataxia.JAMA Neurol. 2015 Nov;72(11):1334-41. doi: 10.1001/jamaneurol.2015.1855. JAMA Neurol. 2015. PMID: 26414159
-
Gender-specific differences in major cardiac events and mortality in lamin A/C mutation carriers.Eur J Heart Fail. 2013 Apr;15(4):376-84. doi: 10.1093/eurjhf/hfs191. Epub 2012 Nov 25. Eur J Heart Fail. 2013. PMID: 23183350
-
A polymorphic miR-155 binding site in AGTR1 is associated with cardiac hypertrophy in Friedreich ataxia.J Mol Cell Cardiol. 2011 Nov;51(5):848-54. doi: 10.1016/j.yjmcc.2011.07.001. Epub 2011 Jul 12. J Mol Cell Cardiol. 2011. PMID: 21771600
-
Arrhythmia risk stratification with regard to prophylactic implantable defibrillator therapy in patients with dilated cardiomyopathy. Results of MACAS, DEFINITE, and SCD-HeFT.Herz. 2004 May;29(3):348-52. doi: 10.1007/s00059-004-2578-0. Herz. 2004. PMID: 15167963 Review.
-
Cardiac monitoring and treatment for children and adolescents with neuromuscular disorders.Dev Med Child Neurol. 2006 Mar;48(3):231-5. doi: 10.1017/S0012162206000491. Dev Med Child Neurol. 2006. PMID: 16483403 Review.
Cited by
-
The Role of Serum Levels of Neurofilament Light (NfL) Chain as a Biomarker in Friedreich Ataxia.Front Neurosci. 2021 Mar 2;15:653241. doi: 10.3389/fnins.2021.653241. eCollection 2021. Front Neurosci. 2021. PMID: 33737864 Free PMC article. No abstract available.
-
Milestones in Friedreich ataxia: more than a century and still learning.Neurogenetics. 2015 Jul;16(3):151-60. doi: 10.1007/s10048-015-0439-z. Epub 2015 Feb 8. Neurogenetics. 2015. PMID: 25662948 Review.
-
Mitochondrial dynamism and heart disease: changing shape and shaping change.EMBO Mol Med. 2015 Jul;7(7):865-77. doi: 10.15252/emmm.201404575. EMBO Mol Med. 2015. PMID: 25861797 Free PMC article. Review.
-
Rationale for the development of 2-aminobenzamide histone deacetylase inhibitors as therapeutics for Friedreich ataxia.J Child Neurol. 2012 Sep;27(9):1164-73. doi: 10.1177/0883073812448533. Epub 2012 Jul 4. J Child Neurol. 2012. PMID: 22764181 Free PMC article. Review.
-
The Therapeutic Potential of Targeting Ferroptosis in the Treatment of Mitochondrial Cardiomyopathies and Heart Failure.J Cardiovasc Pharmacol. 2024 Jan 1;83(1):23-32. doi: 10.1097/FJC.0000000000001496. J Cardiovasc Pharmacol. 2024. PMID: 37816193 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
